The European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended approving Pfizer Inc (NYSE:PFE) and BioNTech SE’s (NASDAQ:BNTX) 3-µg…
Telsa Inc. (NASDAQ: TSLA) will release its third-quarter (Q3) financial results following the market close on Wednesday, Oct. 19.
Analysts anticipate the Austin, Texas-based carmaker will report earnings per share (EPS) of $1.03 and revenues of $22.2 billion.